Insulin Glargine (U-100) Cartridge Systems and Pens and Oxymorphone Extended-Release Tablets
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Oxymorphone Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Oxymorphone Hydrochloride
- Insulin Glargine (U-100) Cartridge Systems and Pens-Oxymorphone Injection
- Insulin Glargine (U-100) Cartridge Systems and Pens-Oxymorphone Tablets
- Insulin Glargine (U-100) Cartridge Systems and Pens-Oxytocin
- Insulin Glargine (U-100) Cartridge Systems and Pens-Oxytocin Intravenous, Intramuscular
- Insulin Glargine (U-100) Cartridge Systems and Pens-Oxytrol
- Oxymorphone Extended-Release Tablets-Insulin Glargine (U-100) Vials
- Oxymorphone Extended-Release Tablets-Insulin Glargine (U-300) Pens
- Oxymorphone Extended-Release Tablets-Insulin glargine and lixisenatide
- Oxymorphone Extended-Release Tablets-Insulin glargine and lixisenatide Subcutaneous
- Oxymorphone Extended-Release Tablets-Insulin glargine, recombinant Subcutaneous
- Oxymorphone Extended-Release Tablets-Insulin glulisine